Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development

por Roestenberg, Meta, Kamerling, Ingrid M. C., de Visser, Saco J.
Publicado 2018

Corrigendum: Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development

por Roestenberg, Meta, Kamerling, Ingrid M. C., de Visser, Saco J.
Publicado 2019

How to expedite early‐phase SARS‐CoV‐2 vaccine trials in pandemic setting—A practical perspective

por van der Plas, Johan L., Roestenberg, Meta, Cohen, Adam F., Kamerling, Ingrid M.C.
Publicado 2020

Assessment of Risks Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Experimental Human Infection Studies

por Kuiper, Vincent P, Rosendaal, Frits R, Kamerling, Ingrid M C, Visser, Leonardus G, Roestenberg, Meta
Publicado 2020

Accelerating vaccine trial conduct in a pandemic with a hot spot‐based inclusion strategy using trial and epidemic simulation

por van der Plas, Johan L., van Esdonk, Michiel J., Kamerling, Ingrid M. C., Cohen, Adam F.
Publicado 2021

The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL‐17822 in healthy male volunteers

por Goulooze, Sebastiaan C., Kruithof, Annelieke C., Alikunju, Shanavas, Gautam, Anirudh, Burggraaf, Jacobus, Kamerling, Ingrid M.C., Stevens, Jasper
Publicado 2020

The Oral Pheneticillin Absorption Test: An Accurate Method to Identify Patients with Inadequate Oral Pheneticillin Absorption

por Dijkmans, Anneke C., Kweekel, Dinemarie M., van Dissel, Jaap T., van Esdonk, Michiel J., Kamerling, Ingrid M. C., Burggraaf, Jacobus
Publicado 2019

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection

por Kuiper, Sander G, Dijkmans, Anneke C, Wilms, Erik B, Kamerling, Ingrid M C, Burggraaf, Jacobus, Stevens, Jasper, van Nieuwkoop, Cees
Publicado 2020

Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season

por Van Der Plas, Johan L., Verdijk, Pauline, Van Brummelen, Emilie M. J., Jeeninga, Rienk E., Roestenberg, Meta, Burggraaf, Jacobus, Kamerling, Ingrid M.C.
Publicado 2019

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resis...

por Vrouwe, Josephina P. M., Kamerling, Ingrid M. C., van Esdonk, Michiel J., Metselaar, Josbert M., Stuurman, Frederik E., van der Pluijm, Gabri, Burggraaf, Jacobus, Osanto, Susanne
Publicado 2021

Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens

por Ortiz Zacarías, Natalia V., Dijkmans, Anneke C., Burggraaf, Jacobus, Mouton, Johan W., Wilms, Erik B., van Nieuwkoop, Cees, Touw, Daan J., Kamerling, Ingrid M. C., Stevens, Jasper
Publicado 2018

First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management

por Moss, Laurence M., Berends, Cecile L., van Brummelen, Emilie M. J., Kamerling, Ingrid M. C., Klaassen, Erica S., Bergmann, Kirsten, Ville, Vanessa, Juarez‐Perez, Victor, Benichou, Annie‐Claude, Groeneveld, Geert Jan
Publicado 2021

Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen

por Zuiker, Rob G. J. A., Ruddy, Marcella K., Morelli, Nicoletta, Mogg, Robin, Rivas, Veronica M., van Dyck, Kristien, De Lepeleire, Inge, Tanen, Michael R. L., Boot, J. Diderik, Kamerling, Ingrid M. C., Diamant, Zuzana
Publicado 2015

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

por in ‘t Veld, Aliede E., Grievink, Hendrika W., van der Plas, Johan L., Eveleens Maarse, Boukje C., van Kraaij, Sebastiaan J. W., Woutman, Tess D., Schoonakker, Mascha, Klarenbeek, Naomi B., de Kam, Marieke L., Kamerling, Ingrid M. C., Jansen, Manon A. A., Moerland, Matthijs
Publicado 2023

A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers

por Berends, Cécile L., Pagan, Lisa, van Esdonk, Michiel J., Klarenbeek, Naomi B., Bergmann, Kirsten R., Moerland, Matthijs, van der Wel, Vincent, de Visser, Saco J., Büller, Hans, de Loos, Frans, de Vries, Wouter S., Waals, Hans, de Leede, Leo G. J., Burggraaf, Jacobus, Kamerling, Ingrid M. C.
Publicado 2021

Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID‐19: A phase 2a, open‐label, single‐dose escalation study

por Prins, Manon L. M., van der Plas, Johan L., Vissers, Maurits F. J. M., Berends, Cécile L., Tresch, Gaby, Soergel, Marianne, Fernández, Elena, van den Berge, Nikita, Duijsings, Daniël, Zitt, Christof, Stavropoulou, Vaia, Zimmermann, Maya, Drake, Roxana F., Burggraaf, Jacobus, Groeneveld, Geert H., Kamerling, Ingrid M. C.
Publicado 2022